Literature DB >> 24798630

Increased faecal calprotectin predicts recurrence of colonic diverticulitis.

Antonio Tursi1, Walter Elisei, Marcello Picchio, Giovanni Brandimarte.   

Abstract

BACKGROUND AND AIMS: Colonic diverticulitis shows a high recurrence rate, but the role of faecal markers in predicting recurrence is unknown. The aim of this study was to investigate the role of faecal calprotectin (FC) in predicting recurrence of diverticulitis. PATIENTS/
METHODS: A prospective cohort study was performed on 54 patients suffering from acute uncomplicated diverticulitis (AUD) diagnosed by computerized tomography (CT). After remission, patients underwent to clinical follow-up every 2 months. After remission and during the follow-up, FC was analysed. Recurrence of diverticulitis was defined as return to our observation due to left lower-quadrant pain with or without other symptoms (e.g. fever), associated with leucocytosis and/or increased C-reactive protein (CRP). Presence of diverticulitis was confirmed by means of CT. RESULTS/
FINDINGS: The mean follow-up was 20 months (range 12-24 months). Forty-eight patients were available for the final evaluation, and six patients were lost to follow-up. During follow-up, increased FC was detected in 17 (35.4 %) patients and diverticulitis recurred in eight patients (16.7 %). Diverticulitis recurred in eight (16.7 %) patients: seven (87.5 %) patients showed increased FC during the follow-up, and only one (12.5 %) patient with recurrent diverticulitis did not show increased FC. Diverticulitis recurrence was strictly related to the presence of abnormal FC test during follow-up.
CONCLUSIONS: In the present prospective study, increased FC was found to be predictive of diverticulitis recurrence.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24798630     DOI: 10.1007/s00384-014-1884-0

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  30 in total

1.  Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study.

Authors:  A G Røseth; M K Fagerhol; E Aadland; H Schjønsby
Journal:  Scand J Gastroenterol       Date:  1992-09       Impact factor: 2.423

2.  What is the role of endoscopy in predicting Crohn's disease relapse or course?

Authors:  Paul Rutgeerts; Severine Vermeire; Gert Van Assche
Journal:  Inflamm Bowel Dis       Date:  2008-10       Impact factor: 5.325

3.  Predictive value of serologic markers of degree of histologic damage in acute uncomplicated colonic diverticulitis.

Authors:  Antonio Tursi; Walter Elisei; Giovanni Brandimarte; Gian Marco Giorgetti; Fabio Aiello
Journal:  J Clin Gastroenterol       Date:  2010 Nov-Dec       Impact factor: 3.062

4.  The burden of selected digestive diseases in the United States.

Authors:  Robert S Sandler; James E Everhart; Mark Donowitz; Elizabeth Adams; Kelly Cronin; Clifford Goodman; Eric Gemmen; Shefali Shah; Aida Avdic; Robert Rubin
Journal:  Gastroenterology       Date:  2002-05       Impact factor: 22.682

5.  Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease.

Authors:  J A Tibble; G Sigthorsson; S Bridger; M K Fagerhol; I Bjarnason
Journal:  Gastroenterology       Date:  2000-07       Impact factor: 22.682

Review 6.  New physiopathological and therapeutic approaches to diverticular disease of the colon.

Authors:  Antonio Tursi
Journal:  Expert Opin Pharmacother       Date:  2007-02       Impact factor: 3.889

Review 7.  Faecal calprotectin -- a useful tool in the management of inflammatory bowel disease.

Authors:  Emanuel Burri; Christoph Beglinger
Journal:  Swiss Med Wkly       Date:  2012-04-05       Impact factor: 2.193

8.  Subclinical intestinal inflammation in patients with Crohn's disease following bowel resection: a smoldering fire.

Authors:  Cesare Ruffolo; Marco Scarpa; Diego Faggian; Daniela Basso; Renata D'Incà; Mario Plebani; Giacomo C Sturniolo; Nicolò Bassi; Imerio Angriman
Journal:  J Gastrointest Surg       Date:  2009-11-10       Impact factor: 3.452

9.  The clinical picture of uncomplicated versus complicated diverticulitis of the colon.

Authors:  Antonio Tursi; Giovanni Brandimarte; Gianmarco Giorgetti; Walter Elisei; Michele Maiorano; Fabio Aiello
Journal:  Dig Dis Sci       Date:  2008-01-30       Impact factor: 3.199

10.  Faecal calprotectin in colonic diverticular disease: a case-control study.

Authors:  Antonio Tursi; Giovanni Brandimarte; Walter Elisei; Gian Marco Giorgetti; Cosimo Damiano Inchingolo; Fabio Aiello
Journal:  Int J Colorectal Dis       Date:  2008-10-22       Impact factor: 2.571

View more
  4 in total

1.  Is C-reactive protein elevation a common finding in colonic diverticular disease?

Authors:  Mehmet Nesim Aktas; Galip Akturk; Bilal Ergul; Zeynal Dogan; Murat Sarikaya; Levent Filik
Journal:  Indian J Gastroenterol       Date:  2016-03

2.  A randomized double-blind placebo-controlled trial of a multi-strain probiotic in treatment of symptomatic uncomplicated diverticular disease.

Authors:  Charlotte L Kvasnovsky; Ingvar Bjarnason; Ana Nora Donaldson; Roy A Sherwood; Savvas Papagrigoriadis
Journal:  Inflammopharmacology       Date:  2017-05-20       Impact factor: 4.473

3.  Approach to gastroenterological diseases in primary care.

Authors:  Michele Russo; Chiara Miraglia; Antonio Nouvenne; Gioacchino Leandro; Tiziana Meschi; Gian Luigi De' Angelis; Francesco Di Mario
Journal:  Acta Biomed       Date:  2018-12-17

4.  Elevated Faecal Calprotectin in Patients with a Normal Colonoscopy: Does It Matter in Clinical Practice? A Retrospective Observational Study.

Authors:  Henrik Hovstadius; David Lundgren; Pontus Karling
Journal:  Inflamm Intest Dis       Date:  2021-02-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.